Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275535 · ClinicalTrials.gov registry record · Phase 4
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
A Phase 4 study of Kidney Diseases, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT00275535: Completed Phase 4 study of Kidney Diseases, sponsored by Mayo Clinic.
NCT00275535 is a Phase 4 study of Kidney Diseases that has completed, run by Mayo Clinic. The registered enrollment target is 165 participants, below the 1,781-participant average among 38 other Kidney Diseases trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275535, a Phase 4 study of Kidney Diseases, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
Primary Outcome
Glomerular filtration rate (Iothalamate clearance) at 12 months following transplantation.
Conditions Studied
Interventions
- DRUG Sirolimus
- DRUG Prednisone
- DRUG Tacrolimus
- DRUG Mycophenolate mofetil
- DRUG Anti-thymocyte globulin
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2001-04 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
What the finished NCT00275535 record still lists
NCT00275535 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 1,781-participant average among 38 other Kidney Diseases trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Kidney Diseases appearing as the primary indexed condition, and to 5 interventions - of which Sirolimus is the first listed.
NCT00275535 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00275535 about?
NCT00275535 is a clinical study titled "The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients". This study was done to find out which treatment, tacrolimus or sirolimus, leads to better long-term kidney function in kidney transplant patients.
What is the current status of trial NCT00275535?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 165 participants. The study started on 2001-04. Estimated completion is 2008-12.
What conditions does trial NCT00275535 study?
This clinical trial studies the following conditions: Kidney Diseases.
What interventions are being tested in trial NCT00275535?
The interventions under investigation include: Sirolimus (DRUG), Prednisone (DRUG), Tacrolimus (DRUG), Mycophenolate mofetil (DRUG), Anti-thymocyte globulin (DRUG).
Who is sponsoring clinical trial NCT00275535?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00275535 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00275535's enrollment target sits among peer trials
165 17th of 38 higher than 22 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RECRUITING · Phase 3
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia